Search Results for: stem cells for ms

Top stem cell & regenerative medicine headlines of the week

Some stem cell news headlines from the past week for you folks. Neuroscience: New nerves for old. Fixing stuff like strokes and paralysis. Cambridge’s Gurdon Institute and Stem Cell Institute receive five-year funding boost. Money flow to stem cells FDA “talks” stem cells in NEJM, “Clarifying Stem-Cell Therapy’s Benefits and Risks”, published on same day that 21st Century […]

Top stem cell & regenerative medicine headlines of the week Read More »

Stem cell clinic lawsuits proliferate with latest against Stemgenex

StemGenex

There is a growing trend of apparently unhappy patients suing stem cell clinics, which have faced more lawsuits recently and some of these cases are proposed class action suits that could have much broader impact. The latest case is against San Diego-based Stemgenex, a clinic that has claimed amongst other things that it can treat numerous diverse afflictions and that

Stem cell clinic lawsuits proliferate with latest against Stemgenex Read More »

20 Nominees for Stem Cell Person of the Year 2016 Award

Stem-cell-person-of-the-year-award

I received a score of great nominations for the Stem Cell Person of the Year 2016 Award and have briefly described the twenty nominees below. The point of the award is to honor the top positive stem cell leader who specifically thinks outside the box and takes risks. I’ve started an on-line vote where you can vote once per day for

20 Nominees for Stem Cell Person of the Year 2016 Award Read More »

Perspectives on Cures Act stem cell provisions possible benefits & risks

EnergyCommerceLogo_ORANGE-e1480522761962

The 21st Century Cures Act has some important provisions that would impact the stem cell and regenerative medicine field.  What is driving these efforts is a widespread sense that the status quo of regenerative medicine oversight isn’t working very well. I’m talking with key stakeholders and still trying to sort out my thoughts on the

Perspectives on Cures Act stem cell provisions possible benefits & risks Read More »

2nd lawsuit alleging a U.S. stem cell clinic caused blindness

Hollywood-Eye-Institute

Concerns over stem cell clinics allegedly causing blindness or other vision problems have been increasing in 2016. If this is in fact happening, the extra sad part of this is that some clinics have claimed that they are doing the opposite: improving vision in patients. What are the concerns? Earlier this year a publicly-traded stem

2nd lawsuit alleging a U.S. stem cell clinic caused blindness Read More »

A feast of post-Thanksgiving stem cell news bites

rainbow-cells-1

Rainbow stem cell clones. From Scientific Reports: NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer. How to harvest stem cells from teeth Stem Cell Transplant Startup With Harvard Tech, Magenta Therapeutics, Gets $48.5M Neurogenic Radial Glia-like Cells in Meninges Migrate and Differentiate into Functionally Integrated Neurons in the Neonatal Cortex (from Cell Stem Cell). Researchers Grow Functioning Human Intestines, Nerves Using Stem

A feast of post-Thanksgiving stem cell news bites Read More »

SCOTS Study on Stem Cells for Vision: Still Questions as Patient Alleges Harm

Eye-injection-e1478306814439

I’m hearing more questions from the community about alleged harm from stem cell clinics selling stem cells for a number of vision-related conditions and some concerns include the so-called SCOTS study. I first blogged about SCOTS early this year and back then I myself had questions too. Some commenters then raised concerns or questions about SCOTS in

SCOTS Study on Stem Cells for Vision: Still Questions as Patient Alleges Harm Read More »

Internal FDA Fighting on Sarepta Bad Omen for Stem Cell Oversight?

Exondys-51-Sarepta-

The FDA caused major controversy by approving the drug Exondys 51 from Sarepta Therapeutics for treating Duchenne muscular dystrophy over the recommendations of a scientific panel it convened that had voted 7-3 against approval. Is this contentious Sarepta approval serve as a sign of how the FDA will deal with stem cells moving forward? Will the FDA approval, which

Internal FDA Fighting on Sarepta Bad Omen for Stem Cell Oversight? Read More »

REGROW Act, Mark Kirk Lobbying & Contributions Yield Stem Cell Surprises

Center-for-Responsive-Politics

The money behind a piece of legislation can provide unique insights into the back story and this is definitely true for the REGROW Act that would reduce FDA oversight of the investigational use of stem cells in patients. Senator Mark Kirk of Illinois, who is facing probable defeat next week in his reelection bid according to

REGROW Act, Mark Kirk Lobbying & Contributions Yield Stem Cell Surprises Read More »

Samantha Yammine: Multiple filters for stem cell research at Canadian stem cell conference

stem-cell-pictures

By Samantha Yammine, PhD Candidate in Derek van der Kooy’s lab at the University of Toronto. See tweets live from #TMM2016 via @SamanthaZY here. Last week, 430 Canadian scientists, trainees, industry professionals, science communicators and international guests gathered in the picturesque ski town of Whistler, British Columbia for the annual Till & McCulloch meeting (TMM).

Samantha Yammine: Multiple filters for stem cell research at Canadian stem cell conference Read More »